CRVO - Company ID 0001053691
The table below shows CervoMed Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $4.01M | $9.74M | $7.14M | $0.00 | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $21.82M | $18.80M | $8.44M | $1.34M | $8.50M | $9.43M |
| SG&A |
CervoMed Inc. reported annual revenue of $4.01M for fiscal year 2025. That is down 58.9% from $9.74M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $40.19K (FY 2010) to $4.01M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $10.48M |
| $9.17M |
| $6.52M |
| $2.14M |
| $7.45M |
| $6.44M |
| Operating income | -$28.29M | -$18.23M | -$7.81M | -$3.48M | -$24.68M | -$15.97M |
| Income tax | $0.00 | - | - | $0.00 | -$443.89K | -$1.68M |
| Net income | -$26.97M | -$16.29M | -$2.17M | -$5.80M | -$24.10M | -$14.19M |
| EPS (diluted) | - | - | - | $2.04M | $1.95M | $53.83M |